Trial
NCT01870791
Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University Hospitals, Leicester
Collaborators
—
Condition
Esophageal Neoplasm
Intervention
Omegaven
Why stopped
Interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-26